Interaction of fibrinogen–magnetic nanoparticle bioconjugates with integrin reconstituted into artificial membranes
Abstract
Magnetic nanoparticles have a broad spectrum of biomedical applications including cell separation, diagnostics and therapy. One key issue is little explored: how do the engineered nanoparticles interact with blood components after injection? The formation of bioconjugates in the bloodstream and subsequent reactions are potentially toxic due to the ability to induce an immune response. The understanding of the underlying processes is of major relevance to design not only efficient, but also safe nanoparticles for e.g. targeted drug delivery applications. In this study, we report on maghemite nanoparticles functionalized with citrate-, dextran- and polyethylene glycol coatings and their interaction with the clotting protein fibrinogen. Further, we investigate using biophysical tools (e.g. dynamic light scattering, circular dichroism spectroscopy and quartz crystal microbalance) the interaction of the magnetic nanoparticles-fibrinogen bioconjugates with artificial cell membranes as a model system for blood platelets. We found that fibrinogen corona formation provides colloidal stability to maghemite nanoparticles. In addition, bioconjugates of fibrinogen with dextran- and citrate-coated NPs interact with integrin-containing lipid bilayer, especially upon treatment with divalent ions, whereas PEG-coating reveals minor interaction. Our study at the interface of protein-conjugated nanoparticles and artificial cell membranes is essential for engineering safe nanoparticles for drug delivery applications.
Related
- Liquid State 31P NMR as a Tool to Leverage the Understanding of Reconstituted Milk Systems
- Dataset and reproducibility package for spectral-window ATR-MIR milk-protein predictions during passive warming of reconstituted skim milk.
- Time-Dependent UV/Ozone Treatment Modulates Platelet Adhesion on Polystyrene and Cyclo-Olefin Polymer through Fibrinogen Orientation.
- Nanotoxicology and Nanoparticle Safety in Biomedical Designs [Correction]
- Imaging Contrast of Diamond Nanoparticle Structures on Different Supporting Films
BibTeX
@article{martens2026interaction,
title = {{Interaction of fibrinogen–magnetic nanoparticle bioconjugates with integrin reconstituted into artificial membranes}},
author = {Ulrike Martens and Una Janke and Sophie Möller and Delphine Talbot and Ali Abou-Hassan and Mihaela Delcea},
journal = {Nanoscale},
year = {2026},
month = sep,
doi = {10.1039/d0nr04181e},
url = {https://hal.science/hal-05768298v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Interaction of fibrinogen–magnetic nanoparticle bioconjugates with integrin reconstituted into artificial membranes
AU - Ulrike Martens
AU - Una Janke
AU - Sophie Möller
AU - Delphine Talbot
AU - Ali Abou-Hassan
AU - Mihaela Delcea
PY - 2026
DA - 2026/09/28
JO - Nanoscale
DO - 10.1039/d0nr04181e
UR - https://hal.science/hal-05768298v1
AB - Magnetic nanoparticles have a broad spectrum of biomedical applications including cell separation, diagnostics and therapy. One key issue is little explored: how do the engineered nanoparticles interact with blood components after injection? The formation of bioconjugates in the bloodstream and subsequent reactions are potentially toxic due to the ability to induce an immune response. The understanding of the underlying processes is of major relevance to design not only efficient, but also safe nanoparticles for e.g. targeted drug delivery applications. In this study, we report on maghemite nanoparticles functionalized with citrate-, dextran- and polyethylene glycol coatings and their interaction with the clotting protein fibrinogen. Further, we investigate using biophysical tools (e.g. dynamic light scattering, circular dichroism spectroscopy and quartz crystal microbalance) the interaction of the magnetic nanoparticles-fibrinogen bioconjugates with artificial cell membranes as a model system for blood platelets. We found that fibrinogen corona formation provides colloidal stability to maghemite nanoparticles. In addition, bioconjugates of fibrinogen with dextran- and citrate-coated NPs interact with integrin-containing lipid bilayer, especially upon treatment with divalent ions, whereas PEG-coating reveals minor interaction. Our study at the interface of protein-conjugated nanoparticles and artificial cell membranes is essential for engineering safe nanoparticles for drug delivery applications.
SN - 2040-3364
SN - 2040-3372
ER -